Inspire Medical Systems (INSP) Tops Q1 EPS by 43c, provides guidance

Inspire Medical Systems (NYSE: INSP) reported Q1 EPS of $0.10, $0.43 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $204.58 million versus the consensus estimate of $200.15 million.

GUIDANCE:

Inspire Medical Systems sees FY2026 EPS of $0.75-$1.25, versus the consensus of $2.03. Inspire Medical Systems sees FY2026 revenue of $825-875 million, versus the consensus of $961.2 million.

For earnings history and earnings-related data on Inspire Medical Systems (INSP) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Brookfield offers A$4.75/sh for Reliance Worldwide - Bloomberg
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown